High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: a study of the European Society for Blood and Marrow Transplantation-Reference-Cited by-同舟云学术

High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: a study of the European Society for Blood and Marrow Transplantation

Published:2019-09-18 Issue:2 Volume:55 Page:376-383
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Spreafico F., ,Dalissier A.,Pötschger U.,Locatelli F.,Michon J. M.,Peters C.^ORCID,Bader P.,Bisogno G.^ORCID,Yeomanson D.,Willasch A.,van den Heuvel Eibrink M.,Graf N.^ORCID,Dallorso S.

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-019-0661-7.pdf

Reference31 articles.

1. Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5 a population-based study. Lancet Oncol. 2014;15:35–47.

2. Graf N, Van Tinteren H, Bergeron C, Pein F, van den Heuvel-Eibrink MM, Sandstedt B, et al. Characteristics and outcome of stage II and III non-anaplastic Wilms’ tumour treated according to the SIOP trial and study 93-01. Eur J Cancer. 2012;48:3240–48.

3. Pritchard-Jones K, Bergeron C, de Camargo B, van den Heuvel-Eibrink MM, Acha T, Godzinski J, et al. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms’ tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Lancet. 2015;386:1156–64.

4. Gratias EJ, Dome JS, Jennings LJ, Chi YY, Tian J, Anderson J, et al. Association of chromosome 1q gain with inferior survival in favorable-histology Wilms Tumor: a report from the Children’s Oncology Group. J Clin Oncol. 2016;34:3189–94.

5. Spreafico F, Biasoni D, Lo Vullo S, Gandola L, D’Angelo P, Terenziani M, et al. Results of the third AIEOP cooperative protocol on Wilms tumor (TW2003) and related considerations. J Urol. 2017;5:1138–45.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Childhood Wilms tumor, relapsed more than 20 years after diagnosis;REV COLOMB CANCEROL;2023

2. Advances in the clinical management of high‐risk Wilms tumors;Pediatric Blood & Cancer;2023-04-25

3. Advances in the clinical management of high‐risk Wilms tumors;Pediatric Blood & Cancer;2023-01-10

4. Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only − the SIOP 93–01 and 2001 protocols;European Journal of Cancer;2022-03

5. High‐dose chemotherapy followed by autologous stem cell rescue in Wilms tumors: French report on toxicity and efficacy;Pediatric Blood & Cancer;2021-11-22